Medical nonprofit, Novo Nordisk Foundation, published its 2022 financial report including on its endowment.
"Annual Report 2022," Novo Nordisk Foundation, 2022, accessed September 25, 2023
. . .
Points of focus in 2022
In relation to health, we continue to build on our legacy by supporting prevention and treatment of diabetes and other cardiometabolic diseases. In 2022 we signed an agreement with the Faroese Government on the establishment of Steno Diabetes Centre Faroe Islands. This will be the last in a series of seven Steno Diabetes Centers that cover the entire Danish Realm, for which we have awarded a total of DKK 7.9 billion.
Another major health challenge high on our agenda is global epidemic preparedness – an issue that COVID-19 has brought into focus. In the spring of 2022, we established the Pandemic Antiviral Discovery (PAD) initiative in close partnership with the Bill & Melinda Gates Foundation and Open Philanthropy. The purpose of this initiative is to accelerate the discovery and development of antiviral drug candidates in preparation for future pandemic threats, and to ensure equitable access to drugs and treatments on a global scale.
In 2022 we have supported research projects and initiatives that focus on improving our food and agricultural systems and on developing new climate change-mitigating solutions. As a foundation, we wish to pave the way for a more sustainable society, and in a year of major climate events and energy and food supply crises due to war, the sense of urgency has only been underlined
. . .